Cepheid PCR testing reagents

Ended Awarded Last action

Contract number
36C24521F0015
Awardee
Awarding agency
Obligated
$416,807

Award facts

Contract value 100% obligated
$416,807.21 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sunnyvale, CA 94089, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 -$8,920
Supplemental Agreement for work within scope P00009 $8,920
Supplemental Agreement for work within scope P00008 $9,055
Exercise an Option P00007 · Cepheid PCR testing reagents - exercise option year 4. $124,991
Funding Only Action P00006 -$83
Exercise an Option P00005 · Cepheid PCR testing reagents - exercise option year 3. $33,591
Funding Only Action P00004 $93,690
Exercise an Option P00003 $37,751
Supplemental Agreement for work within scope P00002 · Cepheid PCR testing reagents - increase in funds and quantity of mrsa kits. $45,930
Exercise an Option P00001 $34,130
Original award $37,751
Show all 11

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order to Cepheid Inc. for Cepheid PCR testing reagents with an ultimate completion date of September 30, 2025. This firm fixed-price contract, valued at $416,807.21, represents an exercise of option year 4 under a larger indefinite delivery vehicle and carries no set-aside designation. Cepheid, headquartered in Sunnyvale, California, is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for infectious diseases and clinical testing. The company's GeneXpert diagnostic systems and associated reagents are widely deployed across federal healthcare systems to detect conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases.

This award is part of Cepheid's broader contractual relationship with the VA, which includes two significant IDV contracts—one with VISN 6 valued at $32.8 million through 2030 and another with VISN 21 valued at $2.5 million—both providing molecular diagnostic testing solutions on a firm fixed-price basis. The reagent supplies and testing capabilities delivered under this order support the VA's clinical laboratory operations and diagnostic capacity across the Veterans Integrated Service Network 5 healthcare facilities, enabling rapid and accurate pathogen detection to support patient care and infection control efforts.

Quick answers

Who was awarded contract 36C24521F0015?

36C24521F0015 was awarded to Cepheid by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 1, 2020.

How much is contract 36C24521F0015 worth?

The government has obligated $416,807 on 36C24521F0015.

Is contract 36C24521F0015 an order under another contract?

Yes. 36C24521F0015 is a delivery order under GS07F0597T, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 36C24521F0015 competed?

The extent of competition for 36C24521F0015 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award